EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Gabapentinoids for Neuropathic Pain After Spinal Cord Injury: An Updated Meta‐Analysis of Randomized Controlled Trials

Rafael Batista João iD, Jilly Octoria Tagore Chan, Ewen Shengyao Huang, Genesis Pamela Mora Rosas, Aníbal Valencia Vasquez, Sanjana Thota, Julyana Medeiros Dantas iD

Pain Practice · 2025-09 · 25 (7)

DOI: 10.1111/papr.70060 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Pain Practice, online erschienen am 19.07.2025. Verfasst von Rafael Batista João und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurophysiology, Goiânia Neurological Institute, Goiânia, GO, Brazil. Hauptthemen laut MEDLINE: Analgesics, Gabapentin, Neuralgia, Spinal Cord Injuries. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Spinal cord injury (SCI) is a debilitating condition frequently associated with chronic symptoms such as central neuropathic pain (CNP) and its related complications. Gabapentinoids are often used in the treatment of post‐SCI CNP; however, the optimal management of this condition is still unclear. This study aimed to assess the efficacy and safety of gabapentinoids compared with placebo in post‐SCI patients affected by CNP.

Methods

We systematically searched PubMed, Embase, and Cochrane Library databases for randomized controlled trials (RCTs) comparing gabapentinoids (gabapentin, pregabalin, or mirogabalin) with placebo in post‐SCI patients experiencing CNP. We calculated mean differences (MD) and risk ratios (RR) for continuous and dichotomous outcomes, respectively, with 95% confidence intervals (CI). Pain was measured on a 0 to 10 numerical rating scale.

Results

We included 5 RCTs comprising 682 patients. The mean age was 50.2 years, and 83.8% were male. When compared with placebo, patients treated with gabapentinoids experienced a significant decrease in average daily pain (MD −1.75; 95% CI: −3.23 to −0.28; p = 0.02) and pain‐related sleep interference (MD −0.99; 95% CI: −1.38 to −0.60; p < 0.001). Additionally, there were higher proportions of individuals with pain intensity relief ≥ 50% (RR 2.19; 95% CI: 1.47 to 3.25; p < 0.001) and with at least some perceived improvement on the clinical global impression scale (RR 1.71; 95% CI: 1.34 to 2.18, p < 0.001) in the gabapentinoids group compared to the placebo group. However, treatment with gabapentinoids was associated with a significantly increased risk of blurred vision (RR 8.55; 95% CI: 1.53 to 47.7; p = 0.02), somnolence (RR 3.77; 95% CI: 2.44 to 5.84; p < 0.001), peripheral edema (RR 2.86; 95% CI: 1.37 to 5.99; p < 0.01), and dizziness (RR 2.83; 95% CI: 1.67 to 4.78; p < 0.001).

Conclusion

In this meta‐analysis of RCTs evaluating patients with CNP following SCI, gabapentinoids were associated with significant improvements in pain and pain‐related sleep interference compared with placebo. Nonetheless, gabapentinoids significantly increased the risk of adverse events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnalgesicsGabapentinNeuralgiaSpinal Cord InjuriesFemaleHumansMalePregabalinRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

gabapentinmeta‐analysismirogabalinneuropathic painpregabalinspinal cord injurysystematic review

Substanzen

AnalgesicsGabapentinPregabalin

Autor:innen und Institutionen

  • Department of Neurology and Neurophysiology, Goiânia Neurological Institute, Goiânia, GO, Brazil.
  • Division of Neurology, Department of Internal Medicine, São Vicente de Paulo Charity Hospital, Jundiaí, SP, Brazil.
  • Faculty of Medicine, University of Indonesia, Depok, WJ, Indonesia.
  • School of Medicine, National Taiwan University, Taipei, Taiwan.
  • Department of Internal Medicine, University of Guayaquil, Guayaquil, Ecuador.
  • Department of Neuroscience, Universidad Tecnológica de Pereira, Pereira, Colombia.

ORCID-Profile: Rafael Batista João, Julyana Medeiros Dantas

Zitieren

APA

João, R. B., Tagore Chan, J. O., Huang, E. S., Rosas, G. P. M., Vasquez, A. V., Thota, S., & Dantas, J. M. (2025). Gabapentinoids for Neuropathic Pain After Spinal Cord Injury: An Updated Meta‐Analysis of Randomized Controlled Trials. Pain Practice, 25(7). https://doi.org/10.1111/papr.70060

Vancouver

João RB, Tagore Chan JO, Huang ES, Rosas GPM, Vasquez AV, Thota S, et al. Gabapentinoids for Neuropathic Pain After Spinal Cord Injury: An Updated Meta‐Analysis of Randomized Controlled Trials. Pain Practice. 2025;25(7). doi:10.1111/papr.70060

BibTeX
@article{Joo2025,
  author = {João, Rafael Batista and Tagore Chan, Jilly Octoria and Huang, Ewen Shengyao and Rosas, Genesis Pamela Mora and Vasquez, Aníbal Valencia and Thota, Sanjana and Dantas, Julyana Medeiros},
  title = {Gabapentinoids for Neuropathic Pain After Spinal Cord Injury: An Updated Meta‐Analysis of Randomized Controlled Trials},
  journal = {Pain Practice},
  year = {2025},
  volume = {25},
  number = {7},
  doi = {10.1111/papr.70060}
}
Kostenlos starten →